Two autistic patients suffering from extreme cases of self-injurious behavior received an association of a sedative neuroleptic, a β-adrenoceptor blocking agent and an opiate antagonist. Within a few weeks after introduction, self-injurious behavior ended. Both patients have been followed-up for more than two years and have not relapsed.